Syndrome  >>  Aptivus (tipranavir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aptivus (tipranavir) / Boehringer Ingelheim
NCT00352066: Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

Completed
1
18
US
apricitabine
Avexa
HIV Infection
08/06
08/06
NCT00344123: Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects

Completed
1
29
US
Tipranavir/Ritonavir, Aptivus, Rosuvastatin, Crestor
Johns Hopkins University, Boehringer Ingelheim
HIV Infections
05/08
05/08
NCT00076999: Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children

Completed
1
115
US, Canada, Europe, RoW
TPV oral solution, RTV oral solution
Boehringer Ingelheim
HIV Infections
06/10
 

Download Options